{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"PolyPid Ltd."},"Symbol":{"label":"Symbol","value":"PYPD"},"Address":{"label":"Address","value":"18 HASIVIM STREET,P.O BOX 7126, PETACH TIKVA, 495376, Israel"},"Phone":{"label":"Phone","value":"+972 747195700"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Middle East"},"CompanyDescription":{"label":"Company Description","value":"PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies."},"CompanyUrl":{"label":"Company Url","value":"https://www.polypid.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Anthony J. Senagore","title":"Senior Medical Director"},{"name":"Dalit Hazan","title":"EVP-Regulatory Affairs, Research & Development"},{"name":"Dikla Czaczkes Akselbrad","title":"Chief Executive Officer & Director"},{"name":"Olga Belotserkovsky","title":"Manager-Clinical Development"},{"name":"Ori Warshavsky","title":"Chief Operating Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}